Company / PP&E per Share
Xenon Pharmaceuticals Inc. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.11
FY2025
5-year range
$0.10 / $0.14
FY2021-FY2025
Trend
-16.6%
vs FY2024
Sector context
#96 of 191
Health Care
What the data says
At $0.11, Xenon Pharmaceuticals Inc.'s pp&e per share ranks #96 of 191 in the Health Care sector. PP&E per Share has fluctuated over the past 10 years, ranging from $0.06 in FY2018 to $0.14 in FY2023.
Based on SEC 10-K filings.
0.11 in FY2025 with a 5-year CAGR of +1.4%.
Declined from $0.14 to $0.11 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +0.8%
- 5-Year CAGR
- +1.4%
- 10-Year CAGR
- -
Sector benchmark
#96 of 191 in Health CareTop 50% of 191This company $0.11 Sector average $22.34
▼
-99.5% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share decreased 16.6% year-over-year.
- Ranks #96 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2023.
- Lowest pp&e per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.51 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.11 | -16.6% |
| FY2024 | $0.13 | -8.6% |
| FY2023 | $0.14 | +34.4% |
| FY2022 | $0.11 | +4.9% |
| FY2021 | $0.10 | -0.5% |
| FY2020 | $0.10 | +60.8% |
| FY2019 | $0.06 | +16.2% |
| FY2018 | $0.06 | -7.7% |
| FY2017 | $0.06 | -38.9% |
| FY2016 | $0.10 | -30.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026